BioCentury
ARTICLE | Financial News

MicuRx raises $25 million in B round

August 22, 2013 11:25 PM UTC

Antibiotics company MicuRx Pharmaceuticals Inc. (Hayward, Calif.) raised $25 million in a series B round led by new investor BVCF, a private equity firm that invests in the life sciences in China. Existing investors Morningside Group and Devon Park Bioventures also participated. BVCF's Weixin Xu and Davis Yang will join MicuRx's board. ...